Mark Montebello

Also affiliated with Alcohol and Drug Foundation, UNSW Sydney, Cooperative Trials Group for Neuro-Oncology, Northern Sydney Local Health District, National Centre for Clinical Research on Emerging Drugs

MedicinePsychology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence”.

Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence

International Journal of Drug Policy(2021)10.1016/j.drugpo.2021.103492

N/A

2.1DataRank · unranked

52 citations

Jeyran Shahbazi, Marianne Byrne, Jason Grebely, Nicholas Lintzeris, Mark S. Chambers +13 more

96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial

International Journal of Drug Policy(2024)10.1016/j.drugpo.2024.104390

N/A

0.730DataRank · unranked

21 citations

Jeyran Shahbazi, Mark S. Chambers, Marianne Byrne, Jaleh Gholami, Emma Zahra +14 more